The US Cannot Afford the Price of Expensive Specialty Drugs
Although drug development is expensive, the high prices being charged for some specialty drugs, like Sovaldi, are not required to induce innovation, Len M. Nichols, PhD, wrote Monday for Morning Consult.
Avoid Unnecessary Cancer Screening Following Venous Thromboembolism, Says NEJM Study
A study published in the New England Journal of Medicine says a CT scan following a first venous thromboebolism event may not benefit in detecting cancer.
Oncogene Study Identifies Drug Resistance in BRAF/PTEN-Null Melanoma
Using mass-spectrometry—based phosphoproteomics, researchers at the Moffit Cancer Center have identified a mechanism by which BRAF/PTEN-null melanoma cells develop resistance to BRAF inhibitors.
The Problem With Informed Consent as It Is Practiced
While the concept of informed consent it a good one, there is a fundamental problem with the informed consent and how it is practiced today, writes Harlan Krumholz, MD, SM, professor of cardiology, epidemiology, and public health.
Challenges in Oncology Practice
